ImageneBio Inc
IMA
Rank in Stocks
#23162
ImageneBio Inc (IMA) is a biotechnology company with therapies currently... ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Share Price
$3.97
Last synced: 2026-11-09
Market Cap
$45.07M
Change (1 day)
-3.29%
Change (1 year)
-53.89%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ImageneBio Inc (IMA)
Category
Healthcare
EPS for ImageneBio Inc (IMA)
EPS as of June 2026 TTM: $-5.21
According to ImageneBio Inc's latest financial reports, its current EPS (TTM) is $-5.21. At the end of 2025 the company had an EPS of $-9.64, an increase over its 2024 EPS of $-40.52.
EPS history for ImageneBio Inc from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-5.21 | -45.95% |
| 2025 | $-9.64 | -76.21% |
| 2024 | $-40.52 | 106.73% |
| 2023 | $-19.60 | -14.04% |
| 2022 | $-22.80 | 100.35% |
| 2021 | $-11.38 | -23.16% |
| 2020 | $-14.81 | 163.06% |
| 2019 | $-5.63 | -58.85% |
| 2018 | $-13.68 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -400.58% |
US
|
|
| $-7.07 | 35.70% |
US
|
|
| $-5.29 | 1.54% |
AU
|
|
| $12.88 | -347.22% |
BE
|
|
| $21.56 | -513.82% |
NL
|
Questions about ImageneBio Inc's earnings per share (EPS)
What is ImageneBio Inc's earnings per share (EPS)?
ImageneBio Inc's earnings per share (EPS) over the last twelve months is $-5.21, as of Jun 2026.
What was ImageneBio Inc's earnings per share (EPS) in 2025?
In 2025, ImageneBio Inc's earnings per share (EPS) was $-9.64, compared with $-40.52 in 2024.
How has ImageneBio Inc's earnings per share (EPS) changed since 2020?
From 2020 to 2025, ImageneBio Inc's earnings per share (EPS) was highest in 2025 ($-9.64) and lowest in 2024 ($-40.52).
How does ImageneBio Inc's earnings per share (EPS) compare with similar companies?
ImageneBio Inc's earnings per share (EPS) ($-5.21) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.